Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On May 7, 2024, Cryoport announced “disappointing” first quarter earnings for fiscal 2024. Jerrell Shelton, CEO of Cryoport, attributed the weak earnings to a “difficult environment globally” and “softer than anticipated” revenue growth in the company’s Life Sciences Services segment. On this news, Cryoport’s stock price fell $3.20 per share or nearly 20% in the span of just a day.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| NVO | Novo Nordisk A/S | March 25, 2025 | Join |
| GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
| NEM | Newmont Corporation | April 01, 2025 | Join |
| GSK | GSK plc | April 07, 2025 | Join |
| NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
| MRK | Merck & Co., Inc. | April 14, 2025 | Join |
| VG | Venture Global, Inc. | April 18, 2025 | Join |
| STZ | Constellation Brands, Inc. | April 21, 2025 | Join |
| SWKS | Skyworks Solutions, Inc. | May 05, 2025 | Join |